🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 8 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/12/2016 31,30 33,05 30,45 32,35 +1,09% 8,31% 1.033.400
06/12/2016 31,05 32,13 30,05 32,00 +3,73% 6,70% 963.500
05/12/2016 30,60 31,15 30,05 30,85 +1,98% 3,59% 617.600
02/12/2016 30,45 31,40 29,95 30,25 -0,98% 4,76% 879.600
01/12/2016 31,70 31,85 30,00 30,55 -4,08% 5,84% 1.037.100
30/11/2016 32,20 32,25 31,55 31,85 -0,93% 2,17% 1.016.200
29/11/2016 31,50 32,45 31,45 32,15 +2,39% 3,17% 813.000
28/11/2016 32,65 33,00 31,25 31,40 -4,41% 5,36% 930.600
25/11/2016 32,75 33,20 32,15 32,85 +1,23% 3,21% 477.400
23/11/2016 33,50 33,65 31,25 32,45 -5,53% 7,16% 2.438.500
22/11/2016 35,00 35,35 33,80 34,35 -2,00% 4,43% 950.100
21/11/2016 35,85 36,10 34,55 35,05 -2,64% 4,32% 738.600
18/11/2016 36,75 36,75 35,78 36,00 -1,50% 2,64% 933.700
17/11/2016 36,50 36,80 35,60 36,55 +0,14% 3,29% 592.600
16/11/2016 37,50 37,55 36,40 36,50 -2,93% 3,07% 588.700
15/11/2016 36,50 38,20 36,50 37,60 +0,27% 4,66% 760.800
14/11/2016 36,95 37,60 36,78 37,50 +1,90% 2,22% 761.000
11/11/2016 37,70 37,90 36,30 36,80 -1,34% 4,24% 799.600
10/11/2016 34,90 37,85 34,48 37,30 +9,22% 9,66% 1.679.700
09/11/2016 33,05 35,25 32,40 34,15 +7,90% 8,62% 1.540.300
08/11/2016 30,85 32,35 30,65 31,65 +1,44% 5,51% 605.900
07/11/2016 32,80 32,85 30,55 31,20 -2,80% 7,01% 1.626.400
04/11/2016 30,95 33,50 30,95 32,10 +4,73% 8,24% 978.100
03/11/2016 33,55 34,00 30,25 30,65 -8,10% 11,18% 1.255.200
02/11/2016 32,75 34,00 31,95 33,35 +3,73% 6,26% 1.006.800
01/11/2016 31,95 33,15 30,60 32,15 +1,10% 7,98% 1.514.700
31/10/2016 33,15 33,15 31,80 31,80 -4,07% 4,07% 651.800
28/10/2016 34,05 34,80 32,60 33,15 -3,63% 6,46% 733.400
27/10/2016 36,55 36,60 34,35 34,40 -3,10% 6,16% 614.300
26/10/2016 36,45 36,60 34,70 35,50 -2,87% 5,21% 674.900